ARCHIVES

NCI Grants Payline Could Reach 175 Under Final Fiscal 1985 Awards Level Of Approximately 1,000

This article is from The Cancer Letter archive.

Vol. 11 No. 32 | August 9, 1985

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

July 13, 2007

Zofran Label Change Includes Warnings of QT Prolongation

September 30, 2011

Natural Substance Blocks Androgen Activity In Vitro

April 27, 2001

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989

Justice Department Clears SWOG Study Of Breast Cancer Treatment Costs

November 17, 1995

GM Corp, to Reimburse Marrow Transplants for Breast Cancer

March 15, 1996